New pharmacon allows testicular tumors to shrink

(University of Bonn) A new active pharmaceutical ingredient may help against severe forms of testicular cancer, which only respond inadequately to other therapies. In mice, the substance kills degenerated cells and allows testicular tumors to shrink. Researchers at the University of Bonn were able to demonstrate this in a recent study. However, first clinical trials are still pending. The work has now been published in the 'Journal of Cellular and Molecular Medicine'.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news